[Drugs Interacting with Coumarine Oral Anticoagulants (author's Transl)]

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1973 Nov 15

PMID 4593987

Citations 6

Authors

R Gugler

H J DENGLER

Affiliations

Soon will be listed here.

Citing Articles

Factors responsible for interindividual differences in the dose requirement of phenprocoumon.

Trenk D, Althen H, Jahnchen E, Meinertz T, Oie S Eur J Clin Pharmacol. 1987; 33(1):49-54.

PMID: 3691595 DOI: 10.1007/BF00610379.

Enhanced elimination of warfarin during treatment with cholestyramine.

Jahnchen E, Meinertz T, Gilfrich H, Kersting F, Groth U Br J Clin Pharmacol. 1978; 5(5):437-40.

PMID: 656283 PMC: 1429341. DOI: 10.1111/j.1365-2125.1978.tb01651.x.

[The influence of diazepam (valium) on the effect of phenprocoumon (marcumar) (author's transl)].

Schunter C, Held H, Schmulling R Klin Wochenschr. 1978; 56(6):305-7.

PMID: 642402 DOI: 10.1007/BF01489177.

[Anticoagulant-induced prophylaxis of thrombosis (author's transl)].

TILSNER V Langenbecks Arch Chir. 1977; 345:353-8.

PMID: 592988 DOI: 10.1007/BF01305502.

Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats.

Schmidt W, Jahnchen E J Pharmacokinet Biopharm. 1979; 7(6):643-63.

PMID: 529027 DOI: 10.1007/BF01061212.

References

Sellers E, Koch-Weser J . Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids. Clin Pharmacol Ther. 1970; 11(4):524-9. DOI: 10.1002/cpt1970114524. View

Orme M, Breckenridge A, Brooks R . Interactions of benzodiazepines with warfarin. Br Med J. 1972; 3(5827):611-4. PMC: 1785896. DOI: 10.1136/bmj.3.5827.611. View

Burns J, Conney A . Enzyme stimulation and inhibition in the metabolism of drugs. Proc R Soc Med. 1965; 58(11 Part 2):955-60. PMC: 1898669. View

Koch-Weser J . Potentiation by glucagon of the hypoprothrombinemic action of warfarin. Ann Intern Med. 1970; 72(3):331-5. DOI: 10.7326/0003-4819-72-3-331. View

Huthwohl B, Jahnchen E . Displacement of phenprocoumon (Marcumar) from albumin by sulfonylurea compounds, suramin, and ioglycamic acid. Naunyn Schmiedebergs Arch Pharmacol. 1972; 273(3):204-12. DOI: 10.1007/BF00501412. View

Remmer H, Siegert M, Merker H . [INCREASE IN DRUG OXIDIZING ENZYME ACTIVITY WITH TOLBUTAMIDE]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964; 249:71-84. DOI: 10.1007/BF00246370. View

Vesell E, Page J . Genetic control of dicumarol levels in man. J Clin Invest. 1968; 47(12):2657-63. PMC: 297437. DOI: 10.1172/JCI105949. View

Levy G, OReilly R, AGGELER P, Keech G . Parmacokinetic analysis of the effect of barbiturate on the anticoagulant action of warfarin in man. Clin Pharmacol Ther. 1970; 11(3):372-7. DOI: 10.1002/cpt1970113372. View

Robinson D, Sylwester D . Interaction of commonly prescribed drugs and warfarin. Ann Intern Med. 1970; 72(6):853-6. DOI: 10.7326/0003-4819-72-6-853. View

10.

Carter S . POTENTIATION OF THE EFFECT OF ORALLY ADMINISTERED ANTICOAGULANTS BY PHENYRAMIDOL HYDROCHLORIDE. N Engl J Med. 1965; 273:423-6. DOI: 10.1056/NEJM196508192730805. View

11.

Brodie B, Weiner M, Burns J, Simson G, YALE E . The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material. J Pharmacol Exp Ther. 1952; 106(4):453-63. View

12.

Solomon H, Schrogie J, Williams D . The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids. Biochem Pharmacol. 1968; 17(1):143-51. DOI: 10.1016/0006-2952(68)90166-4. View

13.

Ikeda M, Ullrich V, Staudinger H . Metabolism in vitro of warfarin by enzymic and nonenzymic systems. Biochem Pharmacol. 1968; 17(8):1663-9. DOI: 10.1016/0006-2952(68)90228-1. View

14.

AGGELER P, OReilly R, Leong L, Kowitz P . Potentiation of anticoagulant effect of warfarin by phenylbutazone. N Engl J Med. 1967; 276(9):496-501. DOI: 10.1056/NEJM196703022760904. View

15.

Sigell L, Flessa H . Drug interactions with anticoagulants. JAMA. 1970; 214(11):2035-8. View

16.

OAKLEY D, LAUTCH H . HALOPERIDOL AND ANTICOAGULANT TREATMENT. Lancet. 1963; 2(7319):1231. DOI: 10.1016/s0140-6736(63)92966-0. View

17.

Garrettson L, Perel J, Dayton P . Methylphenidate interaction with both anticonvulsants and ethyl biscoumacetate. JAMA. 1969; 207(11):2053-6. View

18.

Hansen J, Kristensen M, SKOVSTED L, CHRISTENSEN L . Dicoumarol-induced diphenylhydantoin intoxication. Lancet. 1966; 2(7457):265-6. DOI: 10.1016/s0140-6736(66)92547-5. View

19.

Loeliger E, VAN DER ESCH B, MATTERN M, Hemker H . THE BIOLOGICAL DISAPPEARANCE RATE OF PROTHROMBIN, FACTORS VII, IX AND X FROM PLASMA IN HYPOTHYROIDISM, HYPERTHYROIDISM, AND DURING FEVER. Thromb Diath Haemorrh. 1964; 10:267-77. View

20.

. Interaction between chloral hydrate and warfarin. A report from the Boston Collaborative Drug Surveillance Program, Boston Universtiy Medical Center. N Engl J Med. 1972; 286(2):53-5. DOI: 10.1056/NEJM197201132860201. View